The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

The drug, known as suzetrigine, is the first new painkiller approved in the U.S. since 1998. It can be used to relieve pain after surgery or injury, and some researchers say it might be the start of a ...

“Last year we proved that negotiating for lower drug prices works. Now we plan to build on that record by negotiating for lower prices for 15 additional important drugs for seniors,” Health ...

Pharmaceutical executives last year had said during earnings calls that they don’t expect the new Medicare drug prices to impact their bottom line.Late last year, the Centers for Medicare and ...

About 5.3 million people with Medicare prescription drug coverage used these medications from November 2023 through October 2024 at a cost of $41 billion to the government-funded health program for ...

Great quote on the need for a Prescription Drug Affordability Board from Del ... showing that U.S. consumers pay 258 percent higher prices for prescription drugs than the French do, 244 percent ...

WASHINGTON — Medicare officials announced plans to negotiate the prices of blockbuster diabetes ... Medicare is not allowed to cover Wegovy, the obesity drug, for weight loss alone, but the ...

Your home or property may be repossessed if you do not keep up repayments on your mortgage. The cost of moving home varies significantly depending on whether you're a first-time buyer or are selling a ...

America's largest health care company, UnitedHealth, made profits of more than 5,000 percent on a lifesaving leukemia drug, according ... a debate about the high cost of medical care in the ...

Columbus joined a slough of cities, states and counties in suing drug companies and pharmacy benefit managers who they say artificially raised insulin prices for decades and profited from it ...

But the American Rescue Plan made a major change that hit drug companies with even larger penalties for raising prices. In January 2024, companies that continued to raise a drug’s price would ...